To assess the presence of ILF2 and ILF3 autoantibodies in human disease, we screened human sera from patients with SLE, Sjögren’s syndrome or systemic sclerosis (scleroderma) (Supplementary Fig. 4). The gene discussed is ILF2; the disease is systemic sclerosis.